Business

Panel to discuss long-term illness in workplace

Panelists will include health care, HR professionals

2016 Business 380 Excellence Business Awards at the Hotel at Kirkwood Center in Cedar Rapids on Thursday, Sept. 8, 2016. (Liz Martin/The Gazette)
2016 Business 380 Excellence Business Awards at the Hotel at Kirkwood Center in Cedar Rapids on Thursday, Sept. 8, 2016. (Liz Martin/The Gazette)

What do you do when a valued employee needs to take off work for an extended period of time — weeks or possibly months — due to illness or a family situation? Not just for the employee but for a small business especially, this can be daunting.

Managing long-term illness in the workplace will be the topic for a panel of health care and human-resources professionals at The Gazette’s next Business 380 Excellence Business & Breakfast.

Panelists confirmed so far include:

• Dr. Robin Barnett, primary care physician at Mercy Employee Health Center and president of the Iowa Academy of Family Practice

• Mike Demand, Wellmark Blue Cross and Blue Shield vice president, Health and Care Management

• Linda Reedy, Society for Human Resources Management.

The event, set for Thursday, Oct. 6, at Mercy Medical Center’s Hallagan Education Center, 701 10th St. SE in downtown Cedar Rapids, will begin at 7 a.m. with networking and a light breakfast. The panel discussion and question-and-answer session will run from 7:45 to 9 a.m.

Tickets can be obtained at TheGazette.com/tickets or by calling (319) 398-8345.

Give us feedback

We value your trust and work hard to provide fair, accurate coverage. If you have found an error or omission in our reporting, tell us here.

Or if you have a story idea we should look into? Tell us here.

CONTINUE READING

MORE Business ARTICLES TO READ NEXT ...

Many U.S. businesses may be surprised to learn that the European Union's new data privacy rules could impact them, too. The EU's General Data Protection Regulation (GDPR) will take effect May 25 and imposes strict new rules about ...

Chinese investors are pumping money into U.S. drug start-ups as Beijing seeks to become a global leader in new medicines, adding to a flood of cash flowing to groundbreaking health businesses.Venture-capital funds based in China p ...

Give us feedback

We value your trust and work hard to provide fair, accurate coverage. If you have found an error or omission in our reporting, tell us here.

Or if you have a story idea we should look into? Tell us here.